The ICH Q9 guideline provides a framework for quality risk management (QRM) in the pharmaceutical industry, outlining key principles, processes, and methodologies. It emphasizes the need for science-based decision making in assessing risks to quality throughout a product's lifecycle, including development, manufacturing, and regulatory processes. The document also discusses the importance of stakeholder involvement and communication in the QRM process.